Poised for substantial growth from 
long-read DNA sequencing 

RevoluGen is a privately held company, funded since 2016 by HNW investors committed to its mission of commercialising its products and technologies to advance applications in the field of DNA sequencing.

The company has evolved from an R&D-focused organization to an ambitious and agile organisation focused on rapid commercialization. It has established partnerships for manufacturing, logistics, global customer access, production at scale and automation, with world-leading molecular biology tools companies, and is now open to investment with which to further accelerate its growth in support of the explosive opportunities in long-read DNA sequencing.